UCB risk profile

26 Normal where most of the sector sits

Measured 21 October 2026 from UCB.BR's filed statements. Recomputed nightly.

26 (Normal), driven by Concentration at 44, over 6 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation43ElevatedStableOne-year price volatility — 33.4%
Operating pressure4ContainedEasingOperating-margin drift — +13.2 percentage points
Cash conversion22NormalEasingCapital spending against operating cash — 0.20x
Leverage and coverage11ContainedEasingCurrent ratio — 1.38x
Competitive position29NormalStableRevenue-growth gap against peers — +10.9 percentage points
Concentration44ElevatedStableGeographic concentration — 3,044 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for UCB